Pacer Advisors
PCRX icon

Pacer Advisors’s Pacira BioSciences PCRX Stock Holding History

Pacer Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.32M Buy
235,427
+46,284
+24% +$1.03M 0.02% 600
2025
Q4 		$4.9M Sell
189,143
-11,059
-6% -$263K 0.01% 716
2025
Q3 		$5.16M Sell
200,202
-186,427
-48% -$4.58M 0.01% 673
2025
Q2 		$9.24M Sell
386,629
-215,039
-36% -$5.42M 0.02% 513
2025
Q1 		$15M Sell
601,668
-2,661,169
-82% -$63.7M 0.04% 370
2024
Q4 		$61.5M Sell
3,262,837
-1,699,384
-34% -$29.8M 0.13% 175
2024
Q3 		$74.7M Buy
4,962,221
+2,799,434
+129% +$47.9M 0.16% 161
2024
Q2 		$61.9M Buy
2,162,787
+590,082
+38% +$16.8M 0.14% 178
2024
Q1 		$46M Buy
1,572,705
+531,026
+51% +$16.3M 0.11% 207
2023
Q4 		$35.1M Buy
1,041,679
+1,041,417
+397,487% +$30.5M 0.1% 220
2023
Q3 		$8.04K Sell
262
-10
-4% -$360 ﹤0.01% 2578
2023
Q2 		$10.9K Buy
+272
New +$11.2K ﹤0.01% 3370

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return